BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Maeda O, Matsuoka A, Miyahara R, Funasaka K, Hirooka Y, Fukaya M, Nagino M, Kodera Y, Goto H, Ando Y. Modified docetaxel, cisplatin and capecitabine for stage IV gastric cancer in Japanese patients: A feasibility study. World J Gastroenterol 2017; 23(6): 1090-1097 [PMID: 28246483 DOI: 10.3748/wjg.v23.i6.1090]
URL: https://www.wjgnet.com/1007-9327/full/v23/i6/1090.htm
Number Citing Articles
1
Osamu Maeda, Yuichi Ando. Recent progress of chemotherapy and biomarkers for gastroesophageal cancerWorld Journal of Gastrointestinal Oncology 2019; 11(7): 518-526 doi: 10.4251/wjgo.v11.i7.518
2
Hiroyuki Ohnuma, Yasushi Sato, Naoki Onoyama, Kota Hamaguchi, Naotaka Hayasaka, Masanori Sato, Kazuyuki Murase, Kohichi Takada, Koji Miyanishi, Takeshi Murakami, Tatsuya Ito, Takayuki Nobuoka, Ichiro Takemasa, Junji Kato. Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysisJournal of Cancer Research and Clinical Oncology 2021; 147(8): 2385 doi: 10.1007/s00432-021-03516-7
3
Jun Kinoshita, Takahisa Yamaguchi, Hideki Moriyama, Sachio Fushida. Current status of conversion surgery for stage IV gastric cancerSurgery Today 2021;  doi: 10.1007/s00595-020-02222-0
4
Fei Zhang, Xuanzhang Huang, Yongxi Song, Peng Gao, Cen Zhou, Zhexu Guo, Jinxin Shi, Zhonghua Wu, Zhenning Wang. Conversion Surgery for Stage IV Gastric CancerFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01158
5
Wenjie Zhang, Feng Yu, Yu Wang, Yu Zhang, Lingxin Meng, Yuhua Chi. Rab23 promotes the cisplatin resistance of ovarian cancer via the Shh-Gli-ABCG2 signaling pathwayOncology Letters 2018;  doi: 10.3892/ol.2018.7949
6
Capecitabine/cisplatin/docetaxelReactions Weekly 2017; 1653(1): 92 doi: 10.1007/s40278-017-30520-0